Gary D. Tollefson

Filings by Gary D. Tollefson span 3 companies, the busiest being Orexigen Therapeutics, Inc., RespireRx Pharmaceuticals Inc. and Xenoport Inc. Between 15 February 2006 and 21 December 2007, the trades on record add up to 35 filings.

On the open market, the record shows 1 purchase worth €5,894 and 31 sales worth €310k. On balance, insiders were net sellers of €304k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 3 option exercises. In 2007 alone, the filings show 1 purchase and 31 sales.

The record was last updated on 21 December 2007 with an open-market purchase (€5,894) in RespireRx Pharmaceuticals Inc. Typically, a trade is published a median of 1 day after it takes place. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.